LPL Financial LLC

Position in ARGX — Argenx SE

CIK 1403438 FORT MILL, SC

Position in ARGX

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$16,976,121

-$4,599,292 QoQ

Shares Held

23,247

-9.4% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 8.327956295435971.ToString("F0")% Shared 0.ToString("F0")% None 91.67204370456403.ToString("F0")%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. ARGX ranks #6 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE This page	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,976,121	23,247	-9.4%	Shares	Sole	2026-05-06
2025-12-31	$21,575,413	25,656	-0.4%	Shares	Sole	2026-02-11
2025-09-30	$19,006,921	25,770	+16.8%	Shares	Sole	2025-11-12
2025-06-30	$12,156,605	22,054	+5.6%	Shares	Sole	2025-08-12
2025-03-31	$12,358,141	20,880	+28.0%	Shares	Sole	2025-05-07
2024-12-31	$10,034,955	16,317	+113.4%	Shares	Sole	2025-02-11
2024-09-30	$4,144,743	7,646	+124.8%	Shares	Sole	2024-11-08
2024-06-30	$1,462,566	3,401	+6.3%	Shares	Sole	2024-08-07
2024-03-31	$1,259,116	3,198	+14.8%	Shares	Sole	2024-05-10
2023-12-31	$1,059,877	2,786	+44.3%	Shares	Sole	2024-02-14
2023-09-30	$949,337	1,931	+221.8%	Shares	Sole	2023-11-13
2021-12-31	$210,114	600	-18.6%	Shares	Sole	2022-02-14
2021-09-30	$222,574	737	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.